Pre-control endemicity‡ | Mesoendemic | Hyperendemic | Highly hyperendemic | ||||||
---|---|---|---|---|---|---|---|---|---|
Therapeutic coverage | 60% | 80% | %†change | 60% | 80% | %†change | 60% | 80% | %†change |
Skin microfilarial prevalence§ (%) | 3.46 | 1.84 | 47% | 9.52 | 4.74 | 50% | 27.53 | 16.69 | 39% |
Microfilarial intensity§ (mf/mg) | 1.08 | 0.49 | 55% | 3.1 | 1.31 | 58% | 11.14 | 5.47 | 51% |
Blindness prevalence§ (%) | 0.299 | 0.297 | 0.67% | 0.95 | 0.91 | 4% | 4.25 | 4.13 | 3% |
Visual impairment prevalence§ (%) | 0.4015 | 0.4014 | 0.02% | 1.27 | 1.22 | 4% | 5.7 | 5.54 | 3% |
Troublesome itch prevalence§ (%) | 2.79 | 1.80 | 36% | 9.43 | 3.73 | 32% | 17.38 | 14.09 | 19% |
Excess mortality annual incidence§ (per 1000) | 0.09 | 0.08 | 11% | 0.29 | 0.26 | 10% | 1.39 | 1.13 | 19% |